Compare · BTMD vs CGC
BTMD vs CGC
Side-by-side comparison of Biote Corp. (BTMD) and Canopy Growth Corporation (CGC): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BTMD and CGC operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- CGC is the larger of the two at $2.86B, about 50.4x BTMD ($56.8M).
- CGC has been more active in the news (12 items in the past 4 weeks vs 4 for BTMD).
- CGC has more recent analyst coverage (19 ratings vs 4 for BTMD).
- Company
- Biote Corp.
- Canopy Growth Corporation
- Price
- -
- -
- Market cap
- $56.8M
- $2.86B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 4
- 12
- Recent ratings
- 4
- 19
Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and hemp-based products for recreational and medical purposes primarily in Canada, the United States, and Germany. It operates through two segments, Global Cannabis and Other Consumer Products. The company's products include dried cannabis flowers, oils and concentrates, and softgel capsules. It offers its products under the Tweed, Quatreau, Deep Space, Spectrum Therapeutics, First & Free, TWD, This Works, BioSteel, DNA Genetics CraftGrow, Tokyo Smoke, DOJA, Van der Pop, and Bean & Bud brands. The company also provides growth capital and a strategic support platform that pursues investment opportunities in the global cannabis sector. Canopy Growth Corporation has a clinical research partnership with NEEKA Health Canada and NHL Alumni Association to examine the efficacy of CBD-based therapies as part of the mitigation of persistent post-concussion symptoms. The company was formerly known as Tweed Marijuana Inc. and changed its name to Canopy Growth Corporation in September 2015. Canopy Growth Corporation is headquartered in Smiths Falls, Canada.
Latest BTMD
- Executive Chairman Beer Marc D bought $202,204 worth of shares (131,950 units at $1.53), increasing direct ownership by 122% to 239,744 units (SEC Form 4)
- SEC Form 10-Q filed by Biote Corp.
- Biote Corp. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits
- Biote Reports Second Quarter 2026 Financial Results
- Biote Schedules Second Quarter 2026 Financial Results Release and Conference Call
- Amendment: SEC Form 8-K/A filed by Biote Corp.
- SEC Form 4 filed by Interim CEO Peterson Robert Charles
- SEC Form 4 filed by Director Christensen Bret
- SEC Form 4 filed by Executive Chairman Beer Marc D
- Biote Corp. filed SEC Form 8-K: Leadership Update
Latest CGC
- Officer Gedeon Christelle sold $19,616 worth of shares (13,344 units at $1.47), decreasing direct ownership by 2% to 692,162 units (SEC Form 4) to cover taxes
- Officer Stewart Thomas Carlton sold $3,280 worth of shares (2,231 units at $1.47), decreasing direct ownership by 0.36% to 614,167 units (SEC Form 4) to satisfy withholding obligation
- SEC Form DEFA14A filed by Canopy Growth Corporation
- Canopy Growth Announces Mailing of Proxy Materials for 2026 Annual General and Special Meeting – Urges Shareholders to Vote Now
- SEC Form DEFA14A filed by Canopy Growth Corporation
- Canopy Growth Secures Renewed EU GMP Certification at Kincardine as European Medical Cannabis Business Grows
- SEC Form DEFA14A filed by Canopy Growth Corporation
- SEC Form DEF 14A filed by Canopy Growth Corporation
- Canopy Growth Corporation filed SEC Form 8-K: Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits
- Canopy Growth Corporation filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits